The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...

The supplement market is constantly evolving, with new products appearing regularly, each promising to be the solution to a specific health concern. One such product that has recently caught attention ...

Looking at the universe of stocks we cover at Dividend Channel, on 12/27/24, Medtronic PLC (Symbol: MDT), DENTSPLY SIRONA Inc (Symbol: XRAY), and Danaher Corp (Symbol: DHR) will all trade ex ...

Medtronic remains a "Buy" due to its undervalued stock, recent product launches, and resolved supply chain issues, despite underperformance over the past 7 months. The company posted solid Q2 ...

We are aware of reports regarding supply issues of insulin in the UK. Here’s the latest information on how your treatment may be impacted.

The insulin called Afrezza is created and manufactured by MannKind Corporation, and is used to improve glycemic control in adults with diabetes mellitus.“Afrezza is a rapid-acting insulin ...

The GPD Pocket 4 is an 8.8-inch laptop weighing just 770g, that is designed to combine portability with powerful performance. GPD likens its aesthetic to that of an Apple MacBook, highlighting its ...

The t:slim X2 insulin pump with Control-IQ technology is the #1-rated automated insulin delivery (AID) system 1, and now the first and only insulin pump in Canada that is integrated with both ...